Effect of endoscopic ultrasound guided celiac plexus block on the palliation of pain in chronic pancreatitis (EPOCH Trial): study protocol for a randomized multicenter sham-controlled trial {1}
C. Mel Wilcox,Ji Young Bang,James Buxbaum,Timothy B. Gardner,Robert Hawes,Prashant Kedia,Samuel H. Mardini,Thiruvengadam Muniraj,Udayakumar Navaneethan,Veeral M. Oza,Paul Tarnasky,Shyam Thakkar,Irving Waxman,Shyam Varadarajulu,on behalf of the US Pancreatic Disease Study Group,Akwi Asombang,Chloe Bennett,Yan Bi,Wojciech Blogowski,Wei-Shen Chin,Darwin Conwell,Gregory A. Coté,Pramod Garg,Nalini Guda,Yasmin G. Hernandez-Barco,Emily Jonica,Thomas Kowalski,Vivek Kumbhari,Linda Lee,Jorge Machicado,Desiree Morgan,Veeral Oza,Swati Pawa,Rajesh Puri,Amit Rastogi,D. Nageshwar Reddy,Monica Saumoy,Mandeep Sawhney,Santhi Swaroop Vege,Rupjyoti Talukdar,Felix Tellez-Avila,Nikhil Thiruvengadam,Elaina Vivian,Field F. Willingham
DOI: https://doi.org/10.1186/s13063-024-08478-y
IF: 2.728
2024-10-16
Trials
Abstract:Celiac plexus block has been commonly utilized for the treatment of chronic pancreatitis-associated abdominal pain. Prospective studies suggest efficacy in 30 to 50% of patients, although no randomized sham-controlled trials have been performed. The objective of this study is to assess the effect of endoscopic ultrasound (EUS)-guided celiac plexus block on abdominal pain in patients with documented chronic pancreatitis.
medicine, research & experimental